Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Vet Comp Oncol ; 15(4): 1218-1231, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27506920

RESUMEN

We established a new B-cell leukaemia cell line CLB70 from a dog with chronic lymphocytic leukaemia. This cell line is positive for CD20, CD45, CD79a, MHC class II, IgG, IgM; weakly positive for CD21; and negative for CD3, CD4, CD5, CD8, CD14, CD34, CD117. PCR for antigen receptor gene rearrangement (PARR) analysis revealed a biclonal immunoglobulin heavy chain (IgH) gene rearrangement and negative result for TCRγ. Western blot analysis of anti- and pro-apoptotic proteins showed increased expression of Bcl-2, Mcl-1, NF-kB, and Ras, and decreased expression of p53. CLB70 cells grow rapidly in vitro and are tumourigenic in nude mice. The CLB70 line is highly sensitive to doxorubicin, less sensitive to etoposide and imatinib, and resistant to piroxicam, celecoxib and dexamethasone. Our results indicate that CLB70 cells are derived from mature B-cells and they may be a useful tool for the development of new therapeutic strategies for both dogs and humans.


Asunto(s)
Antineoplásicos/uso terapéutico , Enfermedades de los Perros/patología , Leucemia de Células B/veterinaria , Animales , Biomarcadores de Tumor/metabolismo , Western Blotting , Celecoxib/uso terapéutico , Línea Celular Tumoral , Dexametasona/uso terapéutico , Enfermedades de los Perros/tratamiento farmacológico , Perros , Doxorrubicina/uso terapéutico , Resistencia a Antineoplásicos , Etopósido/uso terapéutico , Femenino , Mesilato de Imatinib/uso terapéutico , Leucemia de Células B/tratamiento farmacológico , Leucemia de Células B/patología , Ratones , Trasplante de Neoplasias/veterinaria , Piroxicam/uso terapéutico
2.
Toxicol In Vitro ; 32: 16-25, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26639924

RESUMEN

The lanthanide nano-compounds are well suited to serve as fluorescent and magnetic contrast agents and luminescent labels. Although they are considered as promising materials for bio-imaging and bio-sensors in vivo or in vitro, the amount of data is still insufficient for deep understanding the toxicity of these nanomaterials. This knowledge is of great importance in the light of growing use of the biofunctionalized nanoparticles, which raises some questions about safety of these materials. Despite lanthanide-doped NaGdF4 nanocrystals are considered as non-toxic, here we present the data showing the fatal effect of newly synthetized NaGdF4:Yb(3+):Er(3+) on chosen types of cells. Our studies were performed on two cell lines NIH3T3 fibroblasts, and RAW264.7 macrophages. Cytotoxic properties of NaGdF4:Yb(3+):Er(3+) nanoparticles and their biological effects were studied by assessing cell culture viability (MTS), proliferation and apoptosis. Bare NaGdF4:Yb(3+):Er(3+) nanocrystals were cytotoxic and induced apoptosis of both NIH3T3 and RAW264.7 cells. Their cytotoxicity was reduced by PEGylation, at the expense of minimizing direct interactions between the compound and the cell. On the other hand, coating with silica reduced cell death induced by Yb(3+):Er(3+) codoped NaGdF4 nanocrystals (but proliferation was still inhibited). The NH2-modified silica coated nanoparticles were clearly less cytotoxic than pristine nanoparticles, which suggests that both, silica and PEG coatings are reasonable approaches to decrease cytotoxicity of the nanocrystal labels. The silica and PEG shell, should also enable and simplify further bio-functionalization of these luminescent labels. The authors acknowledge the financial support from: Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (IITD PAN) grant no. 3/15, Polish Ministry of Science and Higher Education, Grant N N507 499538 and from the Wroclaw Research Centre EIT+ within the project "The Application of Nanotechnology in Advanced Materials" - NanoMat (POIG.01.01.02-02-002/08) financed by the European Regional Development Fund (Operational Program Innovative Economy, 1.1.2).


Asunto(s)
Erbio/farmacología , Fluoruros/farmacología , Gadolinio/farmacología , Nanopartículas , Iterbio/farmacología , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Medios de Contraste/química , Medios de Contraste/farmacología , Erbio/química , Fluoruros/química , Gadolinio/química , Macrófagos/efectos de los fármacos , Ratones , Células 3T3 NIH , Nanopartículas/química , Polietilenglicoles/química , Dióxido de Silicio/química , Iterbio/química
3.
Pol J Vet Sci ; 13(4): 731-41, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21370755

RESUMEN

BACKGROUND: The aim of the present study was assessing the possibility of experimental allogenic transplantation of cat cornea endothelial cells, multiplied in vitro, into the anterior chamber of the eyeball in recipient cats. The reason for undertaking the research is the need to develop a method that would help in the cornea treatment in animals with corneal opacification following cataract surgery, as well as lens dislocation, injuries and endothelium degeneration. METHODS: Cats aged 10-12 months were used in the experiment. Cornea fragments consisting of the posterior limiting membrane and posterior epithelium were placed in Iscove's medium with addition of 10% foetal calf serum. Multiplied in vitro cells were injected into the anterior chamber of recipient cats. The cornea was subject to histological, histometric and SEM examination on the 3rd, 7th, 20th and 30th day after the surgery. RESULTS: Micromorphological examination of the cornea showed full restitution of its endothelium 30 days after transplantation. Complete regeneration of structures indispensable for normal functioning of the posterior epithelium occurred as a result of implantation. CONCLUSIONS: In this study the results show that implantation of the cells of posterior corneal epithelium of donor cats, multiplied into vitro and injected into the anterior chamber of recipient cats. The cornea regained its full function, the layer of the posterior epithelium was regenerated and the stroma stabilized, presenting the image of full and proper corneal translucency.


Asunto(s)
Gatos , Trasplante de Córnea/veterinaria , Endotelio Corneal/citología , Endotelio Corneal/trasplante , Animales , Células Cultivadas , Trasplante de Córnea/métodos , Endotelio Corneal/ultraestructura , Macrófagos/fisiología , Trasplante Homólogo
4.
Anticancer Res ; 21(4A): 2677-80, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11724338

RESUMEN

It was previously reported that thymic lymphomas of anti HY-TCR transgenic mice were resistant to ionomycin but were sensitive to 50 microM of etoposide. We selected lymphoma clones with strong expression of anti-apoptotic proteins Bcl-2 or Bcl-xL and found that in contrast to proteins encoded by exogenous genes in other model systems, over-expression of endogenous Bcl-2 and Bcl-xL proteins failed to protect against etoposide-induced apoptosis. Susceptibility of lymphoma cells was not diminished even to suboptimal concentration of 0.5 microM of etoposide. Treatment with etoposide did not decrease the ratio of anti-apoptotic Bcl-2 and Bcl-xL proteins to pro-apoptotic Bax protein. Results presented here suggest that high expression of Bcl-2 and Bcl-xL may not diminish susceptibility of T-cell lymphomas to chemotherapy with etoposide.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Etopósido/farmacología , Linfoma/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/biosíntesis , Neoplasias del Timo/metabolismo , Animales , Apoptosis/fisiología , Linfoma/tratamiento farmacológico , Linfoma/patología , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Proteínas Proto-Oncogénicas c-bcl-2/genética , Neoplasias del Timo/tratamiento farmacológico , Neoplasias del Timo/patología , Proteína bcl-X
6.
Arch Immunol Ther Exp (Warsz) ; 48(1): 43-6, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10722231

RESUMEN

Lymphomagenesis is a multistep process progressively freeing transformed thymocytes from external regulatory signals, i.e. thymic developmental program controlling growth, differentiation or apoptosis. Here we report that cells of thymic lymphoma overexpressing Ras/Raf proteins, initially resistant to TCR-dependent apoptosis but sensitive to dexamethasone- and etoposide-induced cell death, became insensitive to dexamethasone after long-time culture. That transition correlated with a strong increase in the expression of the anti-apoptotic Bcl-2 protein. Interestingly, lymphoma cells were still sensitive to p53-mediated apoptosis induced by etoposide. It suggests that the anti-apoptotic activity of Bcl-2 is correlated with a resistance to glucocorticoid-induced apoptosis but not to p53-mediated apoptosis. The sequence of mutations in the process of lymphomagenesis seems to be composed of at least 3 main hits which equip the cells with independence from external mitogenic signals (activation of Ras/Raf), resistance to inducers of apoptosis (activation of Bcl-2) and generation of cellular heterogeneity (deletion of p53) important in tumor progression.


Asunto(s)
Apoptosis/efectos de los fármacos , Dexametasona/farmacología , Linfoma de Células T/metabolismo , Linfoma de Células T/patología , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Neoplasias del Timo/metabolismo , Neoplasias del Timo/patología , Animales , Resistencia a Medicamentos/genética , Genes p53 , Humanos , Linfoma de Células T/genética , Ratones , Ratones Endogámicos C57BL , Mutación , Neoplasias del Timo/genética , Células Tumorales Cultivadas
7.
Leuk Res ; 24(1): 33-8, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10634643

RESUMEN

Mice with transgenic TCR anti H-Y/Db develop spontaneous thymic tumors with a high frequency (up to 50%). Oncogenicity of TCR transgenes could depend on the deregulated expression of oncoproteins engaged in transduction pathways leading to proliferation or apoptosis. In agreement with this possibility we have found that cells of thymic lymphomas from TCR transgenic mice were largely resistant to TCR-dependent Ca++-mediated apoptosis but not to TCR-independent, p53-mediated (etoposide) apoptosis. Here we show raised expression of Bcl-2 protein in some but not in all thymic lymphoma cell lines. It suggests that the antiapoptotic function of Bcl-2 is not necessary for the process of tumorigenesis and the resistance of these lymphomas to Ca++-mediated apoptosis. On the other hand we show that all thymic lymphomas overexpressed Ras/Raf and L-myc proteins. Stimulation of the Ras/Raf pathway was reported to be required to maintain cell viability by preventing programmed cell death in thymic tumors derived from lck transgenic mice. Similarly, in TCR transgenic lymphomas overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins may be responsible for the resistance of these lymphomas to TCR-mediated apoptosis but not affect p53-mediated apoptosis.


Asunto(s)
Apoptosis/fisiología , Regulación Neoplásica de la Expresión Génica , Genes bcl-2 , Genes myc , Genes ras , Linfoma de Células T/genética , Proteínas de Neoplasias/genética , Proteínas Proto-Oncogénicas c-raf/genética , Receptores de Antígenos de Linfocitos T/genética , Neoplasias del Timo/genética , Animales , Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Apoptosis/genética , Calcio/farmacología , Etopósido/farmacología , Femenino , Antígeno H-Y/genética , Humanos , Linfoma de Células T/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Proteínas de Neoplasias/biosíntesis , Proteínas Proto-Oncogénicas c-bcl-2/biosíntesis , Proteínas Proto-Oncogénicas c-bcl-2/fisiología , Proteínas Proto-Oncogénicas c-myc/biosíntesis , Proteínas Proto-Oncogénicas c-myc/fisiología , Proteínas Proto-Oncogénicas p21(ras)/biosíntesis , Proteínas Proto-Oncogénicas p21(ras)/fisiología , Transducción de Señal/genética , Transducción de Señal/fisiología , Neoplasias del Timo/patología , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/fisiología
8.
Postepy Hig Med Dosw ; 53(4): 531-43, 1999.
Artículo en Polaco | MEDLINE | ID: mdl-10544657

RESUMEN

On the basis of recent reports we discuss the role of Vav in TCR-dependent signaling pathways. The Vav protein is GDP/GTP exchange factor for Rac, which initiates transduction of signals in JNK pathway. Upon stimulation of TCR by antigenic peptides, Vav associates with Zap-70 in TCR/CD3 signaling complex and becomes phosphorylated on Tyr-174 by tyrosine kinase Lck. The function of Vav is modulated by substrates and products of PI3-kinase activated by interaction of CD28 on thymocytes with B7 on antigen presenting cells. The PI3-kinase substrates inhibit activation of Vav, while the products enhance phosphorylation and activation of Vav by Lck. It seems that Vav functions in key point of TCR-mediated signaling pathway, which is regulated by costimulatory molecule (CD28) necessary for negative selection. The Vav-mediated integration of signals results in positive or negative selection of thymocytes.


Asunto(s)
Proteínas Oncogénicas/metabolismo , Complejo Receptor-CD3 del Antígeno de Linfocito T/metabolismo , Timo/metabolismo , Animales , Apoptosis/fisiología , Factores de Intercambio de Guanina Nucleótido/metabolismo , Humanos , Complejo Mayor de Histocompatibilidad/fisiología , Fosforilación , Proteínas Proto-Oncogénicas c-vav , Transducción de Señal
9.
Postepy Hig Med Dosw ; 53(2): 345-50, 1999.
Artículo en Polaco | MEDLINE | ID: mdl-10355299

RESUMEN

The abrogation of apoptosis during development of thymocytes could contribute to the lymphomagenesis of immature thymocytes which otherwise would be deleted. In agreement with this possibility it was found that cells of thymic lymphomas from TCR anty H-Y transgenic mice were resistant to TCR mediated apoptosis. Molecular mechanism responsible for resistance to TCR/Nur77-mediated apoptosis in these lymphomas is discussed.


Asunto(s)
Apoptosis/fisiología , Linfoma/fisiopatología , Receptores de Antígenos de Linfocitos T/genética , Transducción de Señal/fisiología , Neoplasias del Timo/fisiopatología , Animales , Ratones , Ratones Transgénicos
10.
Biochem Biophys Res Commun ; 249(1): 279-82, 1998 Aug 10.
Artículo en Inglés | MEDLINE | ID: mdl-9705872

RESUMEN

We reported previously that thymic lymphomas from mice expressing transgenic TCR autoreactive against male (HY) antigen were resistant to anti-CD3 antibody-mediated induction of apoptosis although they were responding to TCR triggering. To test whether thymic lymphomas were specifically resistant to TCR-dependent Ca(++)-mediated induction of apoptosis, we have measured apoptosis of cells treated with Ca(++)-dependent (ionomycin, A23187) and Ca(++)-independent (etoposide, dexamethasone) inducers of apoptosis. Here we show that, unlike thymocytes, all thymic lymphomas were resistant to Ca(++)-dependent but not to Ca(++)-independent induction of apoptosis. These results excluded a general defect of apoptosis in lymphoma cells and suggested a specific inhibition of the calcium-mediated (TCR-dependent) pathway of apoptosis in lymphomas. Interestingly however, nuclear expression of a specific mediator of TCR-dependent apoptosis Nur77 was induced in ionomycin-resistant lymphomas indicating that, unlike normal thymocytes, thymic lymphomas are resistant to Nur77-mediated apoptosis.


Asunto(s)
Apoptosis , Proteínas de Unión al ADN/genética , Linfoma de Células T/genética , Linfoma de Células T/patología , Neoplasias Experimentales/genética , Neoplasias Experimentales/patología , Factores de Transcripción/genética , Animales , Apoptosis/genética , Regulación Neoplásica de la Expresión Génica , Masculino , Ratones , Ratones Transgénicos , Miembro 1 del Grupo A de la Subfamilia 4 de Receptores Nucleares , Receptores de Antígenos de Linfocitos T/genética , Receptores Citoplasmáticos y Nucleares , Receptores de Esteroides , Transducción de Señal
11.
Int Immunol ; 9(1): 127-38, 1997 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9043954

RESUMEN

To investigate the role of antigen receptor-mediated interactions in lymphomagenesis we have analyzed the influence of alpha beta TCR-mediated selection on the development of spontaneous thymic lymphomas, which appear with a high (up to 50%) frequency in mice expressing a transgenic TCR specific for the male antigen (HY) in the context of H-2Db molecules. To this end we compared the kinetics and the incidence of thymic lymphomas developing in females and males with selecting (H-2b) and non-selecting (H-2k) MHC molecules. The kinetics of development of thymic lymphomas was similar in positively selecting (H-2b females) and non-selecting (H-2k females and males) environments but significantly slower (P < 0.01) in the negatively selecting environment (H-2b male). Injection of lymphoma cells derived from a H-2b female into the thymus of a H-2b male resulted in strong, antigen-specific inhibition of growth, indicating that the slower kinetics of lymphomagenesis in H-2b males could be due, at least partially, to the sensitivity of oncogenically transformed thymocytes to TCR-mediated negative selection. Phenotypic and functional analysis of lymphoma cells indicated that they originated from the stage of pre-TCR-dependent transition of immature CD4-CD8- to CD4+ CD8+ thymocytes, which in H-2b females and males developed into tumors under different environmental pressures. These results failed to provide convincing evidence for the role of positive selection but provided a strong indication that self antigen-induced negative selection, in addition to its well established role in self tolerance, can occasionally act as a tumor surveillance mechanism by eliminating or suppressing growth of thymocytes undergoing oncogenic transformation.


Asunto(s)
Linfoma/etiología , Receptores de Antígenos de Linfocitos T/genética , Neoplasias del Timo/etiología , Animales , Apoptosis/genética , Apoptosis/inmunología , Linfocitos T CD4-Positivos/patología , Linfocitos T CD8-positivos/patología , Diferenciación Celular/genética , División Celular/genética , Transformación Celular Neoplásica/genética , Femenino , Antígenos H-2/genética , Inmunofenotipificación , Cinética , Activación de Linfocitos/genética , Activación de Linfocitos/inmunología , Linfoma/genética , Linfoma/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Subgrupos de Linfocitos T/inmunología , Neoplasias del Timo/genética , Neoplasias del Timo/patología
12.
Postepy Hig Med Dosw ; 51(4): 351-65, 1997.
Artículo en Polaco | MEDLINE | ID: mdl-9446099

RESUMEN

Signals delivered through the beta/gp33 (pre-TCR) and T-cell receptor alpha beta control proliferation and differentiation of thymocytes at two distinct control points of T cell maturation. Interaction between T-cell receptor (TCR) and peptide/MHC complex induce signaling pathways leading to activation of T cell. Signal transduction involves CD3 zeta phosphorylation by Lck tyrosine kinase and activation of ZAP-70 which regulates signaling pathways through PKC, Ca++ and Ras/Raf kinase cascade. Appropriate response of cell is preceded by integration of different signals in the nucleus.


Asunto(s)
Antígenos de Diferenciación de Linfocitos T/fisiología , Receptores de Antígenos de Linfocitos T/metabolismo , Transducción de Señal/fisiología , Linfocitos T/fisiología , Complejo CD3/metabolismo , Proteína Tirosina Quinasa p56(lck) Específica de Linfocito/metabolismo , Complejo Mayor de Histocompatibilidad/fisiología , Proteínas Tirosina Quinasas/metabolismo , Proteína Tirosina Quinasa ZAP-70
13.
Arch Immunol Ther Exp (Warsz) ; 45(4): 307-13, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9523006

RESUMEN

Mice with transgenic T cell receptor (TCR) recognizing H-Y male antigen developed spontaneous lymphomas originated from immature thymocytes, with the surface expression of transgenic TCR and CD4/CD8 co-receptors. During in vitro long-term culture (3 months) some lymphoma cell lines lost the surface expression of TCR and co-receptors. Interestingly, the proteins of transgenic receptor were expressed intracellularly but TCR was not detectable on the surface of the in vitro selected subline in contrast to TCR-positive parental cells maintained in vivo. TCR-negative subline has been found to be slowly growing in vivo (i.p. injection) and less tumorigenic (s.c. injection) than parental TCR positive lymphoma. It seems that the in vivo interactions of lymphoma cells with microenvironment preserve their TCR expression and endow with growth advantage, while the selected in vitro TCR-negative cells lose the tumorigenic potential.


Asunto(s)
Linfoma de Células T/patología , Receptores de Antígenos de Linfocitos T/fisiología , Timo/patología , Animales , Complejo CD3/metabolismo , Relación CD4-CD8 , ADN/genética , Epítopos , Antígeno H-Y/inmunología , Linfoma de Células T/ultraestructura , Masculino , Ratones , Ratones Endogámicos , Ratones Transgénicos , Receptores de Antígenos de Linfocitos T/genética , Timo/ultraestructura , Células Tumorales Cultivadas
14.
Postepy Hig Med Dosw ; 50(2): 113-29, 1996.
Artículo en Polaco | MEDLINE | ID: mdl-8848421

RESUMEN

This article describes the significance of the mouse transgenic model in elucidation of the role and the oncogenic potential of such genes as N-ras, pim-1, bcl-2, myc and p53. The role of gene targetting by homologous recombination in the study of preneoplastic state in the mice model was also discussed.


Asunto(s)
Linfocitos B/inmunología , Activación de Linfocitos/fisiología , Lesiones Precancerosas/fisiopatología , Proto-Oncogenes/fisiología , Linfocitos T/inmunología , Animales , Transformación Celular Neoplásica/genética , Transformación Celular Neoplásica/inmunología , Modelos Animales de Enfermedad , Genes Supresores , Ratones , Ratones Transgénicos
15.
Arch Immunol Ther Exp (Warsz) ; 44(2-3): 103-7, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8915513

RESUMEN

Transgenic mice with alpha beta TCR specific for male antigen (HY) in the context of H-2Db MHC class I were prepared by introduction of transgens into (C57BL/6J x DBA/2J)F1 hybrid mice (H-2b/d), where only H-2b is selective for maturating thymocytes. Founder transgenic mouse was backcrossed to H-2b MHC background. Serological typing of H-2 antigens revealed that transgenic mice do not express H-2d antigens. Unexpectedly, cells of thymic lymphomas, spontaneously developed in about 45% of old B6 (H-2b) transgenic mice and peripheral blood lymphocytes of about 40% of transgenic mice, reacted with anti-H-2d serum (strain 129 mice (H-2b) immunized with thymocytes and splenocytes of BALB/c mice) but not with monoclonal antibodies against H-2d MHC class I antigens. Anti-H-2d serum has been shown to react with thymocytes but not peripheral blood lymphocytes from non-transgenic H-2b mice. The lymphocytes of transgenic mice reacting with anti-H-2d serum could represent disseminating preneoplastic or neoplastic cells expressing antigen encoded outside MHC region and present on the cell surface of immature thymocytes but not lymphocytes in healthy mice.


Asunto(s)
Suero Antilinfocítico/química , Antígenos H-2/inmunología , Antígeno H-Y/inmunología , Linfoma/inmunología , Neoplasias del Timo/inmunología , Animales , Citometría de Flujo , Antígeno de Histocompatibilidad H-2D , Complejo Mayor de Histocompatibilidad/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Ratones Transgénicos , Neoplasias del Timo/etiología
17.
Arch Immunol Ther Exp (Warsz) ; 42(3): 179-83, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7487349

RESUMEN

IL-3-dependent cell line (designated as A-3) from adherent spleen cells was developed. The surface phenotype of A-3 cells was analysed by flow cytometry and determined as ASGM1+, FcR+, Ia+. There was no expression of T cell markers (Th1-CD3-CD4-CD8-), B cell marker (surface Ig) as well as macrophage marker Mac-1 antigen. Although A-3 cells expressed ASGM1, they are lacking NK cytotoxic activity in 4 h Cr release assay with YAC-1 targets. In contrast, A-3 cells are endowed with NC cytotoxic activity as shown in 18 h Cr release assay with WEHI-164 target cells.


Asunto(s)
Citotoxicidad Inmunológica , Gangliósido G(M1)/análisis , Interleucina-3/farmacología , Subgrupos Linfocitarios/inmunología , Bazo/citología , Animales , Adhesión Celular , Línea Celular , Separación Celular , Colágeno , Femenino , Citometría de Flujo , Inmunofenotipificación , Subgrupos Linfocitarios/efectos de los fármacos , Ratones , Ratones Endogámicos CBA
18.
Arch Immunol Ther Exp (Warsz) ; 40(5-6): 263-9, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1340180

RESUMEN

The availability of neoplastic cell lines with well defined growth characteristics has greatly facilitated study of the tumor phenotype, tumor progression and metastatic process. MmB16 cell line has been established in vitro from the B16 mouse melanoma serially passaged in C57BL/6 mice. From MmB16 cells two lectin-resistant (LecR) variants were selected with the use of Aleuria aurantia agglutinin (AAA). The correlation between the lectin resistance and their in vivo growth parameters, especially tumorigenicity and metastatic ability, were evaluated. The local tumor growth and the average survival time of mice after subcutaneous (s.c.) inoculation of AAAR variant cells did not differ significantly from those of the parent MmB16 cells. However, the AAAR variants revealed significantly higher experimental lung colonizing ability after intravenous (i.v.) administration and slightly increased spontaneous metastatic ability after s.c. inoculation, as compared to parent MmB16 cells.


Asunto(s)
Lectinas/farmacología , Melanoma Experimental/secundario , Animales , Resistencia a Medicamentos/genética , Femenino , Variación Genética , Inmunoterapia , Neoplasias Pulmonares/secundario , Masculino , Melanoma Experimental/metabolismo , Melanoma Experimental/terapia , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Polisacáridos/metabolismo
19.
Clin Exp Metastasis ; 8(3): 277-86, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2328548

RESUMEN

The availability of lectin-resistant cell lines with altered carbohydrate moieties in cell surface glycoproteins and glycolipids has greatly facilitated study of the involvement of cellular glycoconjugates in tumor growth and metastasis. We present here a new animal model for metastasis study based on mouse Lewis lung carcinoma LL2 in vitro cell line. From this line, five lectin-resistant variant sublines were selected with the following lectins: wheat germ agglutinin (WGAR), Ricinus communis agglutinin II (RCA IIR) and Aleuria aurantia agglutinin (AAAR). The correlation of the lectin resistance with their in vitro and in vivo growth properties, and especially lung colonizing ability, were investigated. Three WGAR variants with well-preserved tumorigenicity revealed reduced metastatic ability, both spontaneous, after subcutaneous (s.c.) administration and experimental, after intravenous (i.v.) administration. The RCA IIR variant also possessed reduced spontaneous and experimental metastatic ability, but exhibited higher growth rate of local s.c. tumors. The AAAR variant possessed reduced spontaneous metastatic ability but its ability to colonize the lungs after i.v. administration was five-fold higher than that of the parent LL2 line, whereas its tumorigenicity remained unchanged. The relative differences among WGAR variants and parent LL2 line, concerning their experimental metastatic ability, remained similar in cyclophosphamide-modified mice to those in normal recipients.


Asunto(s)
Carcinoma/patología , Variación Genética , Lectinas/antagonistas & inhibidores , Neoplasias Pulmonares/patología , Selección Genética , Animales , Carcinoma/genética , Línea Celular Transformada , Neoplasias Pulmonares/genética , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Metástasis de la Neoplasia , Trasplante de Neoplasias , Fenotipo , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/patología
20.
Cancer Immunol Immunother ; 30(1): 51-6, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2598176

RESUMEN

Metastasis can be inhibited by asialo-GM1-positive spleen cells, and in this paper we show that there are two such spleen cell populations. One population is adherent and non-cytotoxic to YAC cells, whereas the other population is non-adherent and cytotoxic to YAC cells. Both cell populations exert an antimetastatic activity in cyclophosphamide-treated mice that are inoculated with LL2 Lewis lung carcinoma cells. We conclude that the antimetastatic activity is not only exerted by cytotoxic asialo-GM1-positive cells (apparently natural killer cells), but also by adherent, non-cytotoxic asialo-GM1+, Thy1.2-, IgG- cells. This means that the latter exert their antimetastatic activity by a non-cytotoxic mechanism.


Asunto(s)
Gangliósido G(M1) , Glicoesfingolípidos/análisis , Metástasis de la Neoplasia , Bazo/inmunología , Animales , Ciclofosfamida/farmacología , Femenino , Inmunoglobulina G/inmunología , Células Asesinas Naturales/inmunología , Ratones , Linfocitos T/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...